INS and type 2 diabetes mellitus: Although the gene products at CDKN2A/B play roles in many cell types, strong evidence links CDKN2A/B T2D risk-polymorphisms specifically to impaired insulin secretory function in humans, pointing to impact on pancreatic islets as the causative mechanism by which this gene locus drives diabetes risk4–10.